In the final part of this three-part series, Dr. Justin Abbatemarco and Drs. John Chen and Smathorn Thakolwiboon discuss how to approach discontinuation of immunotherapy in clinical practice.
Show reference:
https://www.neurology.org/doi/10.1212/WNL.0000000000213903
